共 50 条
- [41] In vitro activity of ceftazidime-avibactam, imipenem-relebactam, aztreonam-avibactam, and comparators toward carbapenem-resistant and hypervirulent Klebsiella pneumoniae isolates [J]. MICROBIOLOGY SPECTRUM, 2023, 11 (06):
- [44] Carbapenem-Resistant Pseudomonas aeruginosa Spondylodiscitis Treated with Ceftazidime-Avibactam: A Case Report with Literature Review [J]. INFECTION AND DRUG RESISTANCE, 2023, 16 : 5309 - 5317
- [46] Emergence of Ceftazidime-Avibactam Resistance and Decreased Virulence in Carbapenem-Resistant ST11 Klebsiella pneumoniae During Antibiotics Treatment [J]. INFECTION AND DRUG RESISTANCE, 2022, 15 : 6881 - 6891
- [47] Identification of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam from ST11 Carbapenem-Resistant Klebsiella pneumoniae Strains [J]. MICROBIOLOGY SPECTRUM, 2022, 10 (02):
- [49] Epidemiological study of carbapenem-resistant Klebsiella pneumoniae [J]. OPEN MEDICINE, 2018, 13 (01): : 460 - 466
- [50] Risk factors for and clinical outcomes of ceftazidime-avibactam-resistant carbapenem-resistant Klebsiella pneumoniae nosocomial infections: a single-center retrospective study [J]. Infection, 2022, 50 : 1147 - 1154